VR Logo

ATAI Life Sciences N.V. (ATAI) download report


Healthcare | Biotechnology & Pharma Research

ATAI Life Sciences N.V. (ATAI) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company.

IPO Date: 18-Jun-2021

Founder & Chairman of the Supervisory Board: Mr. Christian Angermayer

Co-Founder, MD & CEO: Mr. Florian Brand

Listing: NASDAQ: ATAI

Country: Germany

Headquarters: Berlin,

Website: https://www.atai.life

Key Facts

Market cap: $609.18 Mln

Revenue (TTM): $0.50 Mln

Earnings (TTM): $-205.37 Mln

Cash: $334.91 Mln

Total Debt: $0.73 Mln

Insider's Holding: 9.41%

Liquidity: Low

52 Week range: $2.96 - 20.45

Shares outstanding: 160,732,992

Stock Performance

Time Period ATAI Life Sciences N.V. (ATAI) S&P BSE Sensex S&P Small-Cap 600
YTD-50.33-9.49-17.79
1 month-2.07-2.87-2.72
3 months-26.55-8.59-12.17
1 Year-79.380.81-15.82
3 Years--10.397.14
5 Years--11.116.20
10 Years--12.0010.33
As on 24-Jun-2022